Pediatric ALL Relapse May Be Caused by Mutations From Chemotherapy

OPACC
Aug 11, 2021
1 min read

Chemotherapy is standard care for pediatric acute lymphoblastic leukemia (ALL), but new research shows thiopurines can cause mutations that result in relapse.

Comments

AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy

Study identifies how malaria can lead to childhood cancer

'Phenomenal' - study hailed a significant milestone in child cancer care

FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors

LLS Expands its Global Master Trial for Hard-To-Treat Leukemias in Children

What I Wish I Had Known: A Pediatric Oncologist's Transition to Survivorship Care

Unmasking a hidden threat for optimal ALL treatment in children

Pediatric Patients and Parents Say They Want Straight Talk from Oncologists Even When the Prognosis Is Poor

Yale study links childhood thyroid cancer risk to air and light pollution

Forecasting the future for childhood cancer survivors

Recent Posts

Pediatric ALL Relapse May Be Caused by Mutations From Chemotherapy

Comments

AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy

Study identifies how malaria can lead to childhood cancer

'Phenomenal' - study hailed a significant milestone in child cancer care

FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors

LLS Expands its Global Master Trial for Hard-To-Treat Leukemias in Children

What I Wish I Had Known: A Pediatric Oncologist's Transition to Survivorship Care

Unmasking a hidden threat for optimal ALL treatment in children

Pediatric Patients and Parents Say They Want Straight Talk from Oncologists Even When the Prognosis Is Poor

Yale study links childhood thyroid cancer risk to air and light pollution

Forecasting the future for childhood cancer survivors

Archive

Search By Tags